Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 114 clinical trials
  • 0 views
  • 10 Jan, 2025
  • 1 location
  • 0 views
  • 19 Feb, 2024
  • 2 locations
  • 0 views
  • 19 Feb, 2024
PCSK9i in AAA123  

Please see section 3 of the full protocol Please see section 3 of the full protocol Please see section 3 of the full protocol

  • 0 views
  • 18 Mar, 2025
  • 1 location
ZEUS A research study to see how Ziltivekimab works compared to placebo in patients with cardiovascular disease, chronic kidney disease and inflammation (ZEUS)  

The purpose of this study is to see if the new study drug, Ziltivekimab, can be used to treat people with cardiovascular disease, chronic kidney disease, and inflammation. The ZEUS study will see if Ziltivekimab can reduce the risk of having cardiovascular events (for example, heart attack and stroke). The …

  • 0 views
  • 03 May, 2025
  • 1 location
ExAblate Blood-Brain Barrier (BBB) Disruption for the Treatment of Alzheimer's Disease  

The purpose of this study is to evaluate the safety and efficacy of the ExAblate Model 4000 Type 2.0 System as a tool to disrupt the blood-brain barrier (BBB) in patients with probable Alzheimer's Disease (AD).

alzheimer's disease
  • 0 views
  • 09 May, 2025
  • 3 locations
  • 0 views
  • 25 Apr, 2024
  • 1 location
Nutritional Study of Fish Oil in Skin Quality in Healthy Women test 22222 (OPTIHUD)  

test sync --- The skin acts as a barrier against the external environment and prevents water loss from the body. Aging is a natural process leading to changes in the skin and fish oil has been shown to prevent inflammation, hyperpigmentation and UV-damage. This pilot study will determine skin characteristics …

Accepts healthy volunteers
  • 0 views
  • 19 Feb, 2024
  • 5 locations
A Study to Test Whether BI 771716 Helps People With an Advanced Form of Age-related Macular Degeneration (AMD) Called Geographic Atrophy (VERDANT)  

This study is open to people 50 years or older with an eye condition called geographic atrophy. The purpose of this study is to compare a medicine called BI 771716 with a medicine called pegcetacoplan. BI 771716 is being developed to treat people with geographic atrophy. Pegcetacoplan is a medicine …

  • 0 views
  • 17 Feb, 2025
Prospective Evaluation of a Dose Guidance System for People With Diabetes Initiating Basal Insulin or Using Insulin Injections (DGS)  

A prospective, randomized, single blind, two-arms, multicenter study. The study aims to assess the safety of a dosing-guided system (DGS) that provides direct advice on insulin dosing recommendations and diabetes management to individuals with diabetes using insulin or starting basal insulin therapy, guided by their continuous glucose monitoring (CGM).The study …

  • 0 views
  • 13 May, 2025